Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs. 2011

Longqin Hu, and Xinghua Wu, and Jiye Han, and Lin Chen, and Simon O Vass, and Patrick Browne, and Belinda S Hall, and Christopher Bot, and Vithurshaa Gobalakrishnapillai, and Peter F Searle, and Richard J Knox, and Shane R Wilkinson
Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA. longhu@rutgers.edu

A series of nitrobenzyl phosphoramide mustards and their analogs was designed and synthesized to explore their structure-activity relationships as substrates of nitroreductases from Escherichia coli and trypanosomes and as potential antiproliferative and antiparasitic agents. The position of the nitro group on the phenyl ring was important with the 4-nitrobenzyl phosphoramide mustard (1) offering the best combination of enzyme activity and antiproliferative effect against both mammalian and trypanosomatid cells. A preference was observed for halogen substitutions ortho to benzyl phosphoramide mustard but distinct differences were found in their SAR of substituted 4-nitrobenzyl phosphoramide mustards in E. coli nitroreductase-expressing cells and in trypanosomatids expressing endogenous nitroreductases.

UI MeSH Term Description Entries
D007891 Leishmania A genus of flagellate protozoa comprising several species that are pathogenic for humans. Organisms of this genus have an amastigote and a promastigote stage in their life cycles. As a result of enzymatic studies this single genus has been divided into two subgenera: Leishmania leishmania and Leishmania viannia. Species within the Leishmania leishmania subgenus include: L. aethiopica, L. arabica, L. donovani, L. enrietti, L. gerbilli, L. hertigi, L. infantum, L. major, L. mexicana, and L. tropica. The following species are those that compose the Leishmania viannia subgenus: L. braziliensis, L. guyanensis, L. lainsoni, L. naiffi, and L. shawi. Leishmania (Leishmania),Leishmania (Viannia),Leishmania leishmania,Leishmania viannia,Leishmania leishmanias,Leishmania viannias,Leishmanias,Leishmanias (Leishmania),Leishmanias (Viannia),leishmanias, Leishmania,viannias, Leishmania
D009588 Nitrogen Mustard Compounds A group of alkylating agents derived from mustard gas, with the sulfur replaced by nitrogen. They were formerly used as toxicants and vesicants, but now function as antineoplastic agents. These compounds are also powerful mutagens, teratogens, immunosuppressants, and carcinogens. Compounds, Nitrogen Mustard,Mustard Compounds, Nitrogen
D009601 Nitroreductases Enzymes which reduce nitro groups (NITRO COMPOUNDS) and other nitrogenous compounds. Nitroreductase,Oxidoreductases Acting on other Nitrogenous Compounds as Donors
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities

Related Publications

Longqin Hu, and Xinghua Wu, and Jiye Han, and Lin Chen, and Simon O Vass, and Patrick Browne, and Belinda S Hall, and Christopher Bot, and Vithurshaa Gobalakrishnapillai, and Peter F Searle, and Richard J Knox, and Shane R Wilkinson
April 1998, The Journal of organic chemistry,
Longqin Hu, and Xinghua Wu, and Jiye Han, and Lin Chen, and Simon O Vass, and Patrick Browne, and Belinda S Hall, and Christopher Bot, and Vithurshaa Gobalakrishnapillai, and Peter F Searle, and Richard J Knox, and Shane R Wilkinson
March 2007, Journal of medicinal chemistry,
Longqin Hu, and Xinghua Wu, and Jiye Han, and Lin Chen, and Simon O Vass, and Patrick Browne, and Belinda S Hall, and Christopher Bot, and Vithurshaa Gobalakrishnapillai, and Peter F Searle, and Richard J Knox, and Shane R Wilkinson
June 2003, Journal of medicinal chemistry,
Longqin Hu, and Xinghua Wu, and Jiye Han, and Lin Chen, and Simon O Vass, and Patrick Browne, and Belinda S Hall, and Christopher Bot, and Vithurshaa Gobalakrishnapillai, and Peter F Searle, and Richard J Knox, and Shane R Wilkinson
November 2013, Bioorganic & medicinal chemistry letters,
Longqin Hu, and Xinghua Wu, and Jiye Han, and Lin Chen, and Simon O Vass, and Patrick Browne, and Belinda S Hall, and Christopher Bot, and Vithurshaa Gobalakrishnapillai, and Peter F Searle, and Richard J Knox, and Shane R Wilkinson
February 1994, Journal of medicinal chemistry,
Longqin Hu, and Xinghua Wu, and Jiye Han, and Lin Chen, and Simon O Vass, and Patrick Browne, and Belinda S Hall, and Christopher Bot, and Vithurshaa Gobalakrishnapillai, and Peter F Searle, and Richard J Knox, and Shane R Wilkinson
June 2004, Journal of medicinal chemistry,
Longqin Hu, and Xinghua Wu, and Jiye Han, and Lin Chen, and Simon O Vass, and Patrick Browne, and Belinda S Hall, and Christopher Bot, and Vithurshaa Gobalakrishnapillai, and Peter F Searle, and Richard J Knox, and Shane R Wilkinson
December 1999, Bioorganic & medicinal chemistry letters,
Longqin Hu, and Xinghua Wu, and Jiye Han, and Lin Chen, and Simon O Vass, and Patrick Browne, and Belinda S Hall, and Christopher Bot, and Vithurshaa Gobalakrishnapillai, and Peter F Searle, and Richard J Knox, and Shane R Wilkinson
January 1978, Journal of medicinal chemistry,
Longqin Hu, and Xinghua Wu, and Jiye Han, and Lin Chen, and Simon O Vass, and Patrick Browne, and Belinda S Hall, and Christopher Bot, and Vithurshaa Gobalakrishnapillai, and Peter F Searle, and Richard J Knox, and Shane R Wilkinson
January 1962, Yao xue xue bao = Acta pharmaceutica Sinica,
Longqin Hu, and Xinghua Wu, and Jiye Han, and Lin Chen, and Simon O Vass, and Patrick Browne, and Belinda S Hall, and Christopher Bot, and Vithurshaa Gobalakrishnapillai, and Peter F Searle, and Richard J Knox, and Shane R Wilkinson
December 2019, Bioorganic chemistry,
Copied contents to your clipboard!